Renovacor (AMEX:RCOR) reported quarterly losses of $(0.03) per share. This is a 81.25 percent increase over losses of $(0.16) per share from the same period last year.
See Why Cara Therapeutics (CARA) Stock Is Moving Higher On Tuesday
The FDA has approved Cara Therapeutics Inc (NASDAQ:CARA) and Vifor Pharma AG’s Korsuva (difelikefalin) injection for severe-to-moderate pruritis (itching) in patients with chronic…